Literature DB >> 12386845

The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction.

Kay-E Gottschalk1, Horst Kessler.   

Abstract

Integrins are pivotal proteins in cell-cell adhesion, signaling and apoptosis. These properties render them attractive targets for drugs, especially those involved in cancer treatment. Recently, the structures of the extracellular domains of one of the integrin subtypes was solved with X-ray crystallography in the free form as well as bound to a ligand. These structures in combination with NMR spectroscopic data, electron microscopy images, and molecular modeling provide deeper insight into the mechanism of integrin-mediated signal transduction. The structures make structure-based rational drug design possible and are certainly hallmarks in integrin research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12386845     DOI: 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  29 in total

1.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.

Authors:  Tsan Xiao; Junichi Takagi; Barry S Coller; Jia-Huai Wang; Timothy A Springer
Journal:  Nature       Date:  2004-09-19       Impact factor: 49.962

Review 2.  Interaction and conformational dynamics of membrane-spanning protein helices.

Authors:  Dieter Langosch; Isaiah T Arkin
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

3.  Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation.

Authors:  Kuen Yong Lee; Eben Alsberg; Susan Hsiong; Wendy Comisar; Jennifer Linderman; Robert Ziff; David Mooney
Journal:  Nano Lett       Date:  2004-07-13       Impact factor: 11.189

Review 4.  Insight into nanoparticle cellular uptake and intracellular targeting.

Authors:  Basit Yameen; Won Il Choi; Cristian Vilos; Archana Swami; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

Review 5.  Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.

Authors:  Shi Xu; Bogdan Z Olenyuk; Curtis T Okamoto; Sarah F Hamm-Alvarez
Journal:  Adv Drug Deliv Rev       Date:  2012-09-29       Impact factor: 15.470

6.  Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors.

Authors:  Yunpeng Ye; Sharon Bloch; Baogang Xu; Samuel Achilefu
Journal:  J Med Chem       Date:  2006-04-06       Impact factor: 7.446

7.  Differential diagnosis of solitary pulmonary nodules using ⁹⁹mTc-3P₄-RGD₂ scintigraphy.

Authors:  Qingjie Ma; Bin Ji; Bing Jia; Shi Gao; Tiefeng Ji; Xueju Wang; Zhenguo Han; Guoqing Zhao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-27       Impact factor: 9.236

Review 8.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

9.  Synthesis, characterization, and biological evaluation of integrin alphavbeta3-targeted PAMAM dendrimers.

Authors:  C Andrew Boswell; Peter K Eck; Celeste A S Regino; Marcelino Bernardo; Karen J Wong; Diane E Milenic; Peter L Choyke; Martin W Brechbiel
Journal:  Mol Pharm       Date:  2008-06-07       Impact factor: 4.939

10.  Peptide-mediated cellular uptake of cryptophane.

Authors:  Garry K Seward; Qian Wei; Ivan J Dmochowski
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.